Posts Tagged: myasthenia

COVID and Myasthenia

COVID continues to be a concern if you are immunocompromised or have a weakened immune system because of a medical condition or a treatment for a condition. This is the case if you have myasthenia gravis, and are taking immuno-suppressant medication. The Centers for Disease Control continues to recommenf that those who are immunocompromised or… Read more »

7 Tips for Coping during the Holiday Season

By Maria Zepeda, NBC-HWC, and Julie Rowin, MD   The Holiday Season is upon us, and this means a wonderful time for some and a difficult time for many. We are living through times of uncertainty and ambiguity which can feel overwhelming. Here are some suggestions on how to better cope with the challenges we… Read more »

Oct 25: Emerging Therapies Webinar

Register Now! Emerging Therapies for MG Tuesday, October 25, 2022; 6:30pm Central Speaker: Pritikanta Paul, MD, University of Illinois at Chicago After years of research and clinical trials, a number of new therapies for myasthenia gravis have arrived or will do so soon. Instead of suppressing a person’s entire immune system (as with drugs like… Read more »

MG Activities of Daily Living (MG-ADL) Scale

With a disease like myasthenia that fluctuates from day to day and even more from month to month, it can be challenging to get a clear picture of a person’s illness. Your doctor can assess your myasthenia with several different tracking tools. One of these measures is called the MG Activities of Daily Living scale,… Read more »

Patient Experience with Pyridostigmine

In January 2022, an Illinois-based specialty pharmaceutical company collaborated on a project with Conquer MG to gain insights from MG patients. Conquer MG helped with study review and recruitment, and a study of 102 MG patients was conducted that addressed their use of pyridostigmine (brand name Mestinon®). Pyridostigmine is typically the first drug MG patients… Read more »